A 55-year-old Japanese woman had suffered from follicular lymphoma since June 2005. Although she had undergone several chemotherapies with rituximab and had achieved CR in March 2006, she relapsed in June 2006. She achieved CR again with salvage chemotherapy. On account of her follicular lymphoma the international prognostic index was in the high-risk group, we decided to perform allogeneic haematopoietic SCT (HSCT). As she did not have any suitable sibling donors, we selected an unrelated woman donor who had one locus mismatch HLA phenotype and genotype (DRB1 locus).
In April 2007, she received allogeneic BMT after a reduced-intensity conditioning regimen consisting of TBI (4 Gy/2fr), fludarabine (30 mg/m 2 /day for 6 days) and intravenous BU (0.8 mg/kg Â 4/day for 2 days). Acute GVHD prophylaxis consisted of MTX (15 mg/m 2 on day 1, 10 mg/m 2 on days 3 and 6) and tacrolimus (0.025 mg/kg). Engraftment was achieved on day 17 after BMT, confirmed by complete donor type chimerism using short tandem repeat-based PCR assay. We verified her CR state by BM biopsy, computer tomography imaging and fluorodeoxyglucose positron emission tomography (FDG-PET) imaging after BMT. After engraftment she did not have any complications or acute GVHD, and she was discharged from our hospital on day 66 after BMT.
In October 2007, computer tomography and FDG-PET imaging as follow-up examinations showed swelling of mediastinal and axillary lymph nodes with increased uptake of FDG. After 1 month, new lesions on bilateral pleura were observed by repeated FDG-PET imaging ( Figure 1 ). Serum soluble IL-2 receptor level was elevated to 1622 U/ml at that time, although the level was normal just after HSCT. We suspected that lymphoma had recurred again and performed examinations of bronchoalveolar lavage and transbronchial biopsy from hilar lymph nodes. Examination of bronchoalveolar lavage fluid revealed that lymphocytes had increased and CD4/CD8 ratio of lymphocytes was high. Biopsies showed no evidence of lymphoma recurrence and revealed non-necrotizing granuloma. Serum angiotensin-converting enzyme level was slightly elevated (24.2 IU/l) at that time. To obtain an accurate final diagnosis, we obtained biopsies from mediastinal lymph nodes, pleura and a piece of lung by video-assisted thoracic surgery in January 2008. Pathological examination revealed non-necrotizing granuloma consistent with sarcoidosis in all of the pathological materials and no evidence of infections or malignancy. The greater part of the lymph nodes was occupied by sarcoidosis ( Figure 2 ). IgH/JH gene rearrangement of the lymph nodes was not detected by Southern blotting. We investigated chimerism of lymph nodes in which sarcoidosis had infiltrated using short tandem repeat-based PCR assay. The lymph nodes contained both donor-type and recipienttype cells (89.1 and 10.9%, respectively). We concluded that lymphoma was in a CR state and that she had new donor cell-derived sarcoidosis. She and her donor did not have a past history of sarcoidosis and she did not have a family history of sarcoidosis. She did not have any symptoms and complications in other organs. Therefore, we decided that she should not be treated. Follow-up computer tomography images were unchanged after 6 months and she is still asymptomatic.
Sarcoidosis after HSCT is rare, only nine cases having been reported. [1] [2] [3] [4] [5] Previous study never referred to chimerism of sarcoidosis lesions. This is the first report in which chimerism of lymph nodes where sarcoidosis had infiltrated was investigated and the first study showing that lymph nodes contained mostly donor-type cells. We speculate that abnormality of the immune system after HSCT affected the reconstituted donor cells and triggered the onset of sarcoidosis.
Although causes of sarcoidosis are not yet clear, it seems that CD4-positive T cells, especially differentiated type 1 helper T cells, and their secreted cytokines are important for the formation of granulomas. 6 It is also known that type 1 helper T cells play important roles in acute GVHD after HSCT. It is interesting that GVHD and sarcoidosis have common target organs. Analysis of the pathogenesis of sarcoidosis after HSCT should be useful for investigation of the mechanism underlying the onset of sarcoidosis. Moreover, sarcoidosis lesions can be easily mistaken as relapsed lymphomas. In the setting of lymphomas after HSCT, the development of lymphadenopathy should be treated carefully. More cases need to be studied in the future. 
